Prostate cancer is the most commonly diagnosed cancer in Australian males. It affects one in seven Australian men in their lifetimes and is the fourth most common cause of cancer death.

Despite advances in prostate cancer testing and treatment, 3,323 men died from prostate cancer in 2021.

QUT researchers are developing targeted therapies that actively seek out cancer proteins and kill harmful cells. Further research will look at restoring traditional therapy, shrinking tumours, and improving response to treatment.

This novel approach will provide several new drugs to help fight prostate cancer and progress treatment strategies to improve patient outcomes.

Your gift will:

• Fund vital research to identify novel prostate cancer target proteins
• Allow computer modelling and screening to identify small molecules that could be used as anti-prostate cancer drugs
• Help develop rapid analysis for screening molecules against prostate cancer cells
• Test small molecules for their anti-prostate cancer abilities

The real-world impact of your gift:

Imagine a novel approach to prostate cancer that could improve patient outcomes and save men’s lives.

Your gift will drastically improve precision treatment options, outcomes and quality of life for Australian men diagnosed with prostate cancer helping them be stronger for longer.

• $25 will keep a cancer cell line growing for 6 months
• $50 will test the effect of an anti-cancer drug on the growth and viability of cancer cells
• $600 will fund the purchase of an antibody for researching a new cancer protein target
• $1,000 can be used to produce and purify a particular cancer protein for testing against small molecules
• $10,000 will support the project of a postgraduate student for a year